Key Takeaways:
- Securities fraud class action filed against Stellantis N.V. (NYSE: STLA)
- Class period covers Feb. 26, 2025, to Feb. 5, 2026
- Lead plaintiff deadline is June 8, 2026
Key Takeaways:

Investors filed a securities fraud lawsuit against Stellantis N.V., alleging management concealed earnings deterioration from February 2025 to February 2026.
"Defendants made false and misleading statements and concealed material adverse facts concerning the true state of Stellantis' earnings growth potential," the Rosen Law Firm said in a statement announcing the class action. The lawsuit covers purchasers of Stellantis common stock on the New York Stock Exchange between Feb. 26, 2025, and Feb. 5, 2026.
The complaint alleges Stellantis was not equipped or positioned to grow its adjusted operating income as forecasted, and that electrification was either not growing as management claimed or that the company was not well positioned to capitalize on the opportunity. Stellantis ultimately took considerable charges to adjust its priorities and shift focus away from battery-powered electric vehicles, according to the lawsuit.
Investors who purchased Stellantis shares during the class period may be entitled to compensation without out-of-pocket costs through a contingency fee arrangement. Those seeking to serve as lead plaintiff must file motions with the court by June 8, 2026. A lead plaintiff acts as a representative party on behalf of other class members in directing the litigation.
The Rosen Law Firm, which is representing investors in the case, has recovered over $1 billion for shareholders since its inception and was ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm encourages investors to select qualified counsel with a track record of success in leadership roles.
The lawsuit represents a significant legal challenge for Stellantis, the global automaker formed through the merger of Fiat Chrysler Automobiles and PSA Group. The company's stock performance and investor confidence may face continued pressure as the litigation progresses. Investors will watch for the court's decision on lead plaintiff appointment and any subsequent developments in the discovery process.
This article is for informational purposes only and does not constitute investment advice.